Cancer survivors are at increased risk of sepsis, possibly attributed to weakened physiologic conditions. The aims of this study were to examine the mediation effect of indicators of frailty on the association between cancer survivorship and sepsis incidence and whether these differences varied by race.
Methods:
We performed a prospective analysis using data from the REasons for Geographic and Racial Differences in Stroke cohort from years 2003 to 2012. We categorized frailty as the presence of ≥2 frailty components (weakness, exhaustion, and low physical activity). We categorized participants as “cancer survivors” or “no cancer history” derived from self-reported responses of being diagnosed with any cancer. We examined the mediation effect of frailty on the association between cancer survivorship and sepsis incidence using Cox regression. We repeated analysis stratified by race.
Results:
Among 28 062 eligible participants, 2773 (9.88%) were cancer survivors and 25 289 (90.03%) were no cancer history participants. Among a total 1315 sepsis cases, cancer survivors were more likely to develop sepsis (12.66% vs 3.81%, P < .01) when compared to participants with no cancer history (hazard ratios: 2.62, 95% confidence interval: 2.31-2.98, P < .01). The mediation effects of frailty on the log-hazard scale were very small: weakness (0.57%), exhaustion (0.31%), low physical activity (0.20%), frailty (0.75%), and total number of frailty indicators (0.69%). Similar results were observed when stratified by race.
Conclusion:
Cancer survivors had more than a 2-fold increased risk of sepsis, and indicators of frailty contributed to less than 1% of this disparity.
AngusDCLinde-ZwirbleWTLidickerJClermontGCarcilloJPinskyMR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303–1310.
2.
MartinGSManninoDMEatonSMossM. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554.
3.
WangHEShapiroNIAngusDCYealyDM. National estimates of severe sepsis in United States emergency departments. Crit Care Med. 2007;35(8):1928–1936.
4.
DanaiPAMossMManninoDMMartinGS. The epidemiology of sepsis in patients with malignancy. Chest. 2006;129(6):1432–1440.
5.
SammonJDKlettDESoodA, et al.Sepsis after major cancer surgery. J Surg Res. 2015;193(2):788–794.
6.
WilliamsMDBraunLACooperLM, et al.Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care. 2004;8(5):R291–R298.
7.
RemickDG. Pathophysiology of sepsis. Am J Pathol. 2007;170(5):1435–1444.
8.
Gloeckler RiesLAReichmanMELewisDRHankeyBFEdwardsBK. Cancer survival and incidence from the Surveillance Epidemiology, and End Results (SEER) program. Oncologist. 2003;8(6):541–552.
9.
WelchHGSchwartzLMWoloshinS. Are increasing 5-year survival rates evidence of success against cancer?JAMA. 2000;283(22):2975–2978.
10.
AizerAAWilhiteTJChenMH, et al.Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer. 2014;120(10):1532–1539.
11.
AkinyemijuTFSolimanASYassineMBanerjeeMSchwartzKMerajverS. Healthcare access and mammography screening in Michigan: a multilevel cross-sectional study. Int J Equity Health. 2012;11:16.
12.
AkinyemijuTFSolimanASJohnsonNJ, et al.Individual and neighborhood socioeconomic status and healthcare resources in relation to black-white breast cancer survival disparities. J Cancer Epidemiol. 2013;2013:490472.
13.
AkinyemijuTFSolimanASCopelandGBanerjeeMSchwartzKMerajverSD. Trends in breast cancer stage and mortality in Michigan (1992-2009) by race, socioeconomic status, and area healthcare resources. PLoS One. 2013;8(4):e61879.
14.
AkinyemijuTFVin-RavivNChavez-YenterDZhaoXBudhwaniH. Race/ethnicity and socio-economic differences in breast cancer surgery outcomes. Cancer Epidemiol. 2015;39(5):745–751.
15.
BradleyCJGivenCWRobertsC. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490–496.
16.
CrossCKHarrisJRechtA. Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies. Cancer. 2002;95(9):1988–1999.
17.
DaiD. Black residential segregation, disparities in spatial access to health care facilities, and late-stage breast cancer diagnosis in metropolitan Detroit. Health Place. 2010;16(5):1038–1052.
18.
El-TamerMBHomelPWaitRB. Is race a poor prognostic factor in breast cancer?J Am Coll Surg. 1999;189(1):41–45.
19.
GwynKBondyMLCohenDS, et al.Racial differences in diagnosis, treatment, and clinical delays in a population-based study of patients with newly diagnosed breast carcinoma. Cancer. 2004;100(8):1595–1604.
20.
KimSHFerranteJWonBRHameedM. Barriers to adequate follow-up during adjuvant therapy may be important factors in the worse outcome for Black women after breast cancer treatment. World J Surg Oncol. 2008;6(26):10.
21.
LaiyemoAO. Reducing racial disparity in colorectal cancer burden. Dig Dis Sci. 2014;59(9):2025–2027.
22.
LiCIMaloneKEDalingJR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163(1):49–56.
23.
SheppardVBOppongBAHamptonR, et al.Disparities in breast cancer surgery delay: the lingering effect of race. Ann Surg Oncol. 2015;22(9):2902–2911.
24.
BarnatoAEAlexanderSLLinde-ZwirbleWTAngusDC. Racial variation in the incidence, care, and outcomes or severe sepsis: analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med. 2008;177:
279–284.
25.
MayrFBYendeSLinde-ZwirbleWTPeck-PamlerOMWeissfeldLAAngusDC. Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsis. JAMA. 2010;303(24):2495–2503.
26.
MayrFBYendeSAngusDC. Epidemiology of severe sepsis. Virulence. 2014;5(1):4–11.
27.
FriedLPTangenCMWalstonJ, et al.Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146–M156.
28.
WoodsNFLaCroixAZGraySL, et al.Women’s Health Initiative. Frailty: emergence and consequences in women aged 65 and older in the Women’s Health Initiative Observational Study. J Am Geriatr Soc. 2005;53(8):1321–1330.
29.
WangHEShapiroNIGriffinRSaffordMMJuddSHowardG. Chronic medical conditions and risk of sepsis. PLoS One. 2012;7(10):e48307.
30.
WangHEBaddleyJGriffinRL, et al.Physical inactivity and long-term rates of community-acquired sepsis. Prev Med. 2014;65:58–64.
31.
MohileSGXianYDaleW, et al.Association of a cancer diagnosis with vulnerability and frailty in older Medicare beneficiaries. J Natl Cancer Inst. 2009;101(17):1206–1215.
32.
Perez-ZepedaMUCardenas-CardenasECesariMNavarrete-ReyesAPGutierrez-RobledoLM. Cancer and frailty in older adults: a nested case-control study of the Mexican Health and Aging Study. J Cancer Surviv. 2016;10(4):736–742.
33.
MahalingamMMooreJXDonnellyJPSaffordMMWangHE. Frailty syndrome and risk of sepsis in the REasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. J Intensive Care Med. 2017:1–9.
34.
HowardVJCushmanMPulleyL, et al.The reasons for geographic and racial differences in stroke study: objectives and design. Neuroepidemiology. 2005;25(3):135–143.
35.
SingerMDeutschmanCSSeymourCW, et al.The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810.
36.
BergmannMMCalleEEMervisCAMiracle-McMahillHLThunMJHeathCW. Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol. 1998;147(6):556–562.
37.
Garcia-GarciaFJCarcaillonLFernandez-TresguerresJ, et al.A new operational definition of frailty: the Frailty Trait Scale. J Am Med Dir Assoc. 2014;15(5):371.e377-371.e313.
38.
JohansenKLDalrympleLSDelgadoC, et al.Comparison of self-report-based and physical performance-based frailty definitions among patients receiving maintenance hemodialysis. Am J Kidney Dis. 2014;64(4):600–607.
39.
JohnsenKLChertowGMJinCKutnerNG. Significance of frailty among dialysis patients. J Am Soc Nephrol. 2007;18(11):2960–2967.
40.
WillenbringMLMasseySHGardnerMB. Helping patients who drink too much: an evidence-based guide for primary care clinicians. Am Fam Physician. 2009;80(1):44–50.
PowellTCDonnellyJPGutierrezOMGriffinRLSaffordMMWangHE. Cystatin C and long term risk of community-acquired sepsis: a population-based cohort study. BMC Nephrol. 2015;16:61.
43.
WangHEShapiroNISaffordMM, et al.High-sensitivity C-reactive protein and risk of sepsis. PLoS One. 2013;8(7):e69232.
44.
WangHEGriffinRShapiroNIHowardGSaffordMM. Chronic statin use and long-term rates of sepsis: a population-based cohort study. J Intensive Care Med. 2016;31(6):386–396.
45.
ChaudharyNSDonnellyJPMooreJXBaddleyJWSaffordMMWangHE. Association of baseline steroid use with long-term rates of infection and sepsis in the REGARDS cohort. Crit Care. 2017;21(1):185.
46.
WangHEShapiroNIGriffinRSaffordMMJuddSHowardG. Inflammatory and endothelial activation biomarkers and risk of sepsis: a nested case-control study. J Crit Care. 2013;28(5):549–555.
47.
BaronRMKennyDA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Social Psychol. 1986;51(6):1173–1182.
48.
HayesAFScharkowM. The relative trustworthiness of inferential tests of the indirect effect in statistical mediation analysis: does method really matter?Psychol Sci. 2013;24(10):1918–1927.
49.
HayesAF. Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach. New York: Guilford Press; 2013.
50.
HayesAFPreacherKJ. Statistical mediation analysis with a multicategorical independent variable. Br J Math Stat Psychol. 2014;67(3):451–470.
51.
VanderweeleTJVansteelandtS. Odds ratios for mediation analysis for a dichotomous outcome. Am J Epidemiol. 2010;172(12):1339–1348.
52.
ValeriLVanderweeleTJ. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods. 2013;18(2):137–150.
53.
ValeriLVanderWeeleTJ. SAS macro for causal mediation analysis with survival data. Epidemiology. 2015;26(2):e23–e24.
54.
RiceMSBertrandKAVanderWeeleTJ, et al.Mammographic density and breast cancer risk: a mediation analysis. Breast Cancer Res. 2016;18(1):94.
55.
BennettJAWinters-StoneKMDobekJNailLM. Frailty in older breast cancer survivors: age, prevalence, and associated factors. Oncol Nurs Forum. 2013;40(3):E126–E134.
56.
BrummelNEBellSPGirardTD, et al.Frailty and subsequent disability and mortality among patients with critical illness. Am J Respir Crit Care Med. 2017;196(1):64–72.
57.
SchaapLAPluijmSMDeegDJVisserM. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119(6):526.e9-17.
58.
VisserMPahorMTaaffeDR, et al.Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002;57(5):M326–M332.
59.
MorleyJEVellasBvan KanGA, et al.Frailty consensus: a call to action. J Am Med Dir Assoc. 2013;14(6):392–397.
60.
HandforthCCleggAYoungC, et al.The prevalence and outcomes of frailty in older cancer patients: a systematic review. Ann Oncol. 2015;26(6):1091–1101.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
